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The paired box transcription factor, Pax2, is important for cochlear development in the mouse inner ear. Two mutant alleles of Pax2, a
knockout and a frameshift mutation (Pax21Neu), show either agenesis or severe malformation of the cochlea, respectively. In humans, mutations
in the PAX2 gene cause renal coloboma syndrome that is characterized by kidney abnormalities, optic nerve colobomas and mild sensorineural
deafness. To better understand the role of Pax2 in inner ear development, we examined the inner ear phenotype in the Pax2 knockout mice using
paint-fill and gene expression analyses.We show that Pax2/ ears often lack a distinct saccule, and the endolymphatic duct and common crus
are invariably fused. However, a rudimentary cochlea is always present in all Pax2 knockout inner ears. Cochlear outgrowth in the mutants is
arrested at an early stage due to apoptosis of cells that normally express Pax2 in the cochlear anlage. Lack of Pax2 affects tissue specification
within the cochlear duct, particularly regions between the sensory tissue and the stria vascularis. Because the cochlear phenotypes observed in
Pax2 mutants are more severe than those observed in mice lacking Otx1 and Otx2, we postulate that Pax2 plays a key role in regulating the
differential growth within the cochlear duct and thus, its proper outgrowth and coiling.
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The mammalian inner ear develops from an ectodermal
thickening adjacent to the hindbrain that first invaginates and
later pinches off from the surrounding ectoderm to form a
hollow vesicle known as the otocyst. Through a largely
unknown series of specifications, the simple otocyst differ-
entiates into the complex and multifunctional inner ear. There
are six major sensory organs within the mature mammalian
inner ear. The five vestibular sensory organs, including the
macula utriculi, macula sacculi and three cristae, detect
gravity and linear and angular acceleration, respectively.
The sensory organ of hearing, the organ of Corti, is housed
within the cochlea.
Pax2, Eya1 (Eyes absent) and Gata3 are associated with
syndromic deafness in humans. Mutations in EYA1 and
GATA3 can lead to branchial-oto-renal (BOR) and hypopara-
thyroidism, sensorineural deafness, renal anomaly (HDR)
syndromes, respectively (Abdelhak et al., 1997; Van Esch
et al., 2000). Mutations in PAX2 are associated with renal-0012-1606/$ - see front matter. Published by Elsevier Inc.
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also been reported in some patients (Sanyanusin et al., 1995;
Schimmenti et al., 1997). The etiology of these syndromes in
human deafness remains unclear. In mice, all three genes are
activated early and their expression persists throughout inner
ear development. Consistent with these expression patterns,
knockouts of these gene products severely affect the growth
and morphogenesis of various components of the mouse
inner ear, including the cochlear duct. These results suggest
that these genes have important andmultiple roles in inner ear
development (Karis et al., 2001; Torres et al., 1996; Xu et al.,
1999).
Three mousemodels withmutations in thePax2 gene have
been described. The Krd strain carries a large deletion in
chromosome 19 that includes the Pax2 locus (Keller et al.,
1994). In addition, a Pax2 knockout line (Torres et al., 1996)
and a line with a frameshift mutation in Pax2 (Pax21Neu) that
is identical to a mutation in a human family with renal-
coloboma syndrome (Favor et al., 1996) have been generated.
All three mutant lines suffer kidney and eye defects. Previous
studies report that the inner ears of Pax2 knockout mice
demonstrate agenesis of the cochlea and the spiral ganglion,
but normal development of the vestibular portion of the inner
ear (Torres et al., 1996). The Pax21Neu strain is missing the
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and continuous with the endolymphatic duct (Favor et al.,
1996). In addition, in Pax21Neu inner ears, a distinct saccule
and occasionally, the utricle and ampullae are missing.
To obtain greater insight into how a knockout of the Pax2
gene mediates these inner ear phenotypes, especially within
the cochlea, we investigated the development of the Pax2
knockout inner ears using paint-fill and gene expression
analyses. We examined the expression patterns of Eya1 and
Gata3 in Pax2 mutant cochlea. In the development of the
Drosophila eye, a pax-eya-six hierarchy of gene regulation
cascade has been demonstrated (Halder et al., 1998). A
similar regulatory pathway involving Pax2 and Eya1 could
occur in the mammalian inner ear (Xu et al., 1999). In
addition, while Pax2 and Gata3 are co-expressed in the
ventral region of mouse otocyst, the expression domains of
Pax2 and Gata3 in the dorsal region of the otocyst do not
overlap (Lawoko-Kerali et al., 2002). The Pax2 immunore-
activity is localized medially to the Gata3 positive region.
The lack of Pax2 might result in an expansion of Gata3
expression domain that could contribute to the resulting
inner ear phenotype in Pax2 / inner ears. Our results
suggest that Pax2 does not directly regulate the expression
of either Eya1 or Gata3. Through still unknown molecular
mechanisms, the lack of Pax2 affects the morphogenesis
and tissue specification of the cochlear duct, including the
organ of Corti and stria vascularis, although it does not
necessarily interfere with the production of sensory hair
cells.Materials and methods
Mice and genotyping
The Pax2 knockout line was obtained from Dr. Peter
Gruss’ laboratory and was maintained on a C57Bl/6 back-
ground (Torres et al., 1995). PCR was used to determine
genotype. The wild-type allele for Pax2 was identified using
a forward primer (5V-AACGGTGGCAAGTTGCAGC-
CTCTG-3V) and a reverse primer (5V-CGCGGAGAAG-
GGGTCTGCTTTGCA-3V). Primers designed within the
neomycin gene (forward primer: 5VATCTCCTGTCATCT-
ATCTCCTGTCATCTCACCTTGCT3V; reverse primer: 5V-
CGGTCCGCCACACCCAGC-3V) were used to identify the
mutant allele.
Phenotypic analysis and in situ hybridization
Paint-fill analysis of inner ear gross anatomy was per-
formed according to Morsli et al. (1998). Cryostat tissue
sections were processed for in situ hybridization as de-
scribed (Morsli et al., 1998). A total of 35 Pax2 homozy-
gous embryos was used for gene expression analysis: 11
between 9.5 and 10.5 dpc, 8 between 11.5 and 12.5 dpc and
18 at 15.5 dpc. RNA probes for Bone morphogeneticprotein 4 (Bmp4), Lunatic fringe (Lfng), Orthodenticle 2
(Otx2), Tyrosinase-related protein 2 (Trp2) and Neurofila-
ment protein 68 kDa (NF68) were previously described
(Morsli et al., 1999). RNA probes for Eye-absent 1 (Eya1)
(Xu et al., 1997), Gata3 (Karis et al., 2001), Pax2 (Dressler
et al., 1990), Pendrin (Pnd) (Everett et al., 1999), Myosin
XV (Myo15a) (Anderson et al., 2000), NeuroD1 (Ma et al.,
1998) and Retinaldehyde dehydrogenase enzyme 2 (Raldh2)
(Zhao et al., 1996) were prepared according to cited
references.
Apoptosis and proliferation assays
Apoptotic cells were identified using terminal dUTP
nick-end labeling (TUNEL) method (ApopTag). Cryostat
sections were treated three times with a 2:1 volume of
ethanol/acetic acid solution for 10 min each before follow-
ing the manufacturer’s protocol.
To detect proliferating cells, pregnant mice were injected
intraperitoneally with a labeling reagent containing 10 mM
5-bromo-2V-deoxyuridine (BrdU) and 1 mM 5-fluoro-2V-
deoxyuridine (Cell proliferation Kit, Amersham) at a con-
centration of 0.03 ml/gm body weight 2 h before sacrificing.
Harvested embryos were fixed with 4% paraformaldehyde
and processed for cryosectioning. Frozen sections were
pretreated with proteinase K (5 Ag/ml) for 2 min before
incubating with a 50% formamide solution containing 5
SSC (saline sodium citrate) and 1% SDS for 30 min at
65jC. Anti-BrdU staining was performed according to
manufacturer’s procedures.Results
Paint-fill analysis of Pax2 / mutants
We used the paint-fill technique to evaluate the gross
anatomy of the inner ears from a total of 5 Pax2 homozy-
gous embryos at 12 dpc and 17 embryos between 14.5 and
15.5 dpc. In wild-type embryos at 12 dpc, three separate
inner ear compartments can be distinguished: a medially
positioned endolymphatic duct, a dorsal vestibular compo-
nent containing the vertical and horizontal canal pouches
(Figs. 1A, C, vp, hp) and a ventral auditory component, the
cochlear duct (Figs. 1A, C, cd). In 12 dpc mutant embryos,
the vestibular component appears normal in the mutants
(Fig. 1B). The resorption domain (rd) shown in Fig. 1B is
normal for this age. However, the endolymphatic duct is
malformed and is either broader (Fig. 1B, n = 2), or smaller
than normal (Fig. 1D, n = 3). The cochlear region is wider
than normal and shows a stunted ventral extension (Figs.
1B, D).
By 15.5 dpc, the gross morphogenesis of the inner ear is
nearly complete except for the cochlear duct, which has not
yet acquired its full 1.75 turns (Fig. 2A). Mild (Figs. 2B, E)
and more severe (Figs. 2C, F) mutant inner ear phenotypes
Fig. 1. Paint-filled inner ears of wild-type and Pax2 mutants at 12 dpc. Lateral (A, B) and anterior (C, D) views of wild-type (wt) (A, C) and Pax2 homozygous
knockout ( / ) (B, D) inner ears. (A, C) A wt inner ear consists of three parts: a medial ed, a dorsal vestibular and ventral cochlear component (cd). The
vestibular component consists of vertical and horizontal canal pouches. In mutant inner ears (B), the ed is either short and broad, or smaller (D) than the wt. The
primordial cochlear duct fails to extend in  / embryos (B, D), but the resorption domain in B is normal for this age. Abbreviations: cd, cochlear duct; ed,
endolymphatic duct; hp, horizontal canal pouch; vp, vertical canal pouch; rd, resorption domain. Orientation arrows: A, anterior; D, dorsal; M, medial. Scale
bar = 100 Am.
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2E, F) views. Due to exencephaly, most of the Pax2 mutant
inner ears are mis-oriented with the semicircular canals
laterally displaced and the cochlear duct medially displaced
(Fig. 2C, n = 15/17). Despite the lateral displacement of the
three ampullae and semicircular canals, these structures
formed in all Pax2 / embryos examined. However, theFig. 2. Paint-filled inner ears of wild-type and Pax2 mutants at 15.5 dpc. A, B and
mutant inner ears. (A, D) Awt inner ear showing a fairly mature morphology. (B, E
C and F. The cochlea is shortened, and the common crus and the ed are fused. The s
a Pax2 mutant inner ear with semicircular canals displaced laterally due to exen
cochlea is shortened. However, the fusion between the common crus and the
Abbreviations: asc, anterior semicircular canal; cc, common crus; cd, cochlear d
semicircular canal; s, saccule; u, utricle. Orientation arrows: A, anterior; D, dorsadiameter of the semicircular canals (asc, lsc and psc) and the
size of the ampullae are sometimes smaller (Fig. 2B, n = 5)
or slightly larger (Fig. 2C, n = 6) than normal.
The malformation in the cochlear duct is quite obvious
with less than a single turn (Figs. 2B, E, F). The mutant
cochlear duct is continuous with the endolymphatic duct, a
feature that is also similar in the wild-type inner ear (CantosC are lateral views and D, E and F are anterior views of wild-type (wt) or
) A Pax2 homozygous inner ear with a less severe phenotype than the one in
emicircular canals are slightly thinner than wt. (C, F) A more severe form of
cephaly. The diameter of the semicircular canals is larger than wt, and the
ed (arrow) is at a more ventral location than the specimen shown in E.
uct; ed, endolymphatic duct; lsc, lateral semicircular canal; psc, posterior
l; M, medial.
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saccule and the cochlear duct, and the saccule and the
endolymphatic duct are missing in the mutants (Figs. 2E,
F). A distinct compartment for the saccule is only evident in
three specimens (Fig. 2B, s). However, the endolymphatic
duct and the common crus are invariably fused in all
specimens examined. In most cases, the two structures are
indistinguishable from each other (Fig. 2E, arrow, n = 13).
In others, the fusion occurred near the base of the common
crus and a small but separate endolymphatic duct can be
identified (Fig. 2F, arrow, n = 3). Although we observed
these variations in the phenotype between different speci-
mens, the right and left ears of the same embryo are always
similar (n = 13).
Relationship of Pax2 expression domains with presumptive
sensory patches
To better understand the role of Pax2 in inner ear
development, we first compared the pattern of Pax2 gene
expression with the expression patterns of genes such as
Bmp4 and Lfng that are expressed in specific presumptive
sensory tissues (Morsli et al., 1998). The expression of Pax2
in the mouse inner ear has been described in several
publications (Nornes et al., 1990; Puschel et al., 1992;
Rinkwitz-Brandt et al., 1995, 1996). A more detailed
account of Pax2 expression pattern in the developing mouse
inner ear was reported by Lawoko-Kerali et al. (2002), using
an antibody against the Pax2 protein. They described the
presence of Pax2 immunoreactivity in the medial region of
the newly formed otocyst. As the otocyst develops into
various components, Pax2 is expressed in the endolymphat-
ic duct, in the hair cells of all differentiating sensory
epithelia and in some non-sensory regions (Lawoko-Kerali
et al., 2002).
In a newly formed otocyst, Lfng is broadly expressed in
the antero-ventral lateral and medial regions of the tear
drop-shaped structure. This Lfng positive region is thought
to encompass the neurogenic region as well as the presump-
tive sensory regions for the utricle, saccule and cochlea
(Morsli et al., 1998). At 10.5 dpc, Pax2 expression only
overlaps with the Lfng domain in the medial but not the
lateral region (most likely the neurogenic region, Figs. 3A,
B, brackets) of the otocyst. Even though Pax2 expression
domain is mostly medial, it expands laterally in the more
posterior regions of the otocyst (Figs. 3C, D, arrowheads).
By 11.5 dpc, many neuroblasts have already delaminated
from the otic epithelium. Two separate Lfng expression
domains are present in the inner ear, a dorsal domain that
corresponds to the macula of the utricle (Fig. 3H, mu) and a
more ventral domain that corresponds to the macula of the
saccule and organ of Corti (Fig. 3J, msc; Morsli et al.,
1998). Pax2 expression overlaps only partially with the
macula of the utricle (Figs. 3G, H, bracket). No obvious
overlap of Pax2 expression with the sensory regions for the
saccule and cochlea was observed (Figs. 3I, J). At that level,Pax2 is mostly expressed in the posterior region of the inner
ear.
Bmp4 is expressed in all three presumptive cristae of the
mouse inner ear (Morsli et al., 1998). Fig. 3F illustrates
Bmp4 expression in the presumptive posterior crista (pc) as
well as the anterior and lateral cristae, which are still
connected at this age (Figs. 3E, F, as). The Pax2 expression
domain does not overlap with any of the presumptive cristae
at this stage. In addition, Pax2 is expressed in a small region
anterior to the posterior crista (Fig. 3E, arrow), a region that
most likely corresponds to the base of the common crus in a
mature inner ear.
At 15.5 dpc, Pax2 expression is not detected in most of
the sensory regions except in the medial region of the
macula utriculi (Figs. 4K, L, arrowheads) and the posterior
region of the macula sacculi (Figs. 3O, P, bracket). In the
cochlea, Pax2 expression is robust in the stria vascularis
region (Fig. 3M, sv) but below detection in the Lfng
positive, sensory region (Figs. 3M, N). In addition, Pax2
is expressed in other non-sensory regions such as the roof of
the utricle (Fig. 3K, arrows), endolymphatic duct and lateral
region of the common crus (Fig. 3O, ed, cc). The reported
immunoreactivity of Pax2 in sensory hair cells of all
sensory regions (Lawoko-Kerali et al., 2002) is much more
evident by postnatal day 1 (P1) using in situ hybridization
(Figs. 3Q, S). The identity of the Pax2 positive sensory hair
cells in the organ of Corti was confirmed by probing an
adjacent section for transcripts of a hair cell marker,Myo15a
(Fig. 3R; Anderson et al., 2000).
Sensory organ and ganglion development in Pax2 mutants
Previous reports noted the absence of the spiral ganglion
in Pax2 knockout mice (Torres et al., 1996) and massive cell
death associated with the ganglion in the Pax21neu strain at
14.5 dpc (Favor et al., 1996). We examined the vestibular
and spiral ganglia in the Pax2 / mutants at 15.5 dpc
using RNA probes against NF68, Eya1 and Gata3 tran-
scripts. NF68 and Eya1 are expressed in both vestibular and
spiral ganglia, whereas Gata3 is only expressed in the spiral
ganglion (Kalatzis et al., 1998; Karis et al., 2001). We
observed a decrease in the size of the vestibular ganglion
in some mutant specimens, compared to wild-type (Figs.
4A, B, vg; n = 5/8). However, most of the mutant inner ears
are lacking the spiral ganglion (Figs. 4C, D, sg; n = 2/8).
We further examined whether the lack of neurons in the
ganglia is due to abnormal delamination of neuroblasts from
the otic epithelium at the otocyst stage. At 10.5 dpc, there is
no obvious change in the neurogenic/sensory competent
region in the Pax2 mutants, based on the expression pattern
of Lfng (Figs. 4E, G). As marked by the expression domain
of NeuroD1 (Kim et al., 2001; Liu et al., 2000), the
neurogenic region also appears normal in the mutants (Figs.
4F, H). Also, no obvious change in the size of the ganglion
is observed at 11.5 dpc (Figs. 4I, J, arrowheads), including
the spiral ganglion component as indicated by the expres-
Fig. 3. Normal expression of Pax2 in the developing wild-type mouse inner ear. Cryostat sections of inner ear at 10.5 dpc (A–D), 11.5 dpc (E–J), 15.5 dpc
(K–P), and P1 (Q–S). A, C, E, G, I, K, M, O and Q are 12 Am adjacent sections of B, D, F, H, J, L, N, P and R, respectively. The approximate levels of
sections are indicated in the respective schematic diagrams. (A, B) At 10.5 dpc, Pax2 (A) expression domain overlaps with the Lfng (B) expression domain
medially but not laterally (brackets). In posterior sections, Pax2 (C) still overlaps with Lfng (D) medially, but Pax2 is also expressed on the lateral side
(arrowheads). (E, F) At 11.5 dpc, Pax2 (E) is not expressed in the Bmp4 positive, presumptive cristae (F), but is expressed in the small region located anterior to
the posterior crista (arrow). (G, H) Pax2 (G) expression overlaps partially with the Lfng positive, macula utriculi (H, mu). Brackets in G and H mark the region
of overlap between Pax2 and Lfng. (I, J) Pax2 (I) expression is predominantly in the posterior pole at the level of the macula sacculi and cochlea (J, msc). (K,
L) At 15.5 dpc, Pax2 (K) is expressed in the medial sensory (arrowheads) and non-sensory (arrows) regions of the cochlea. Pax2 expression within the cristae
and the rest of the macula utriculi is below the level of detection. (M, N) Pax2 (M) is expressed in the stria vascularis (sv) and not in the Lfng positive sensory
region of the cochlea (N). (O, P) Pax2 (O) is expressed in the medial saccule, the ed and lateral region of the common crus. Brackets in O and P mark the region
of overlap in the macula sacculi between Pax2 and Lfng. (Q, R) At P1, Pax2 (Q) is expressed in the stria vascularis and sensory hair cells (arrows) in the organ
of Corti that are also positive for Myo15a (R). One inner and three outer hair cells can be discerned in R. A long arrow points toward the neural side (inner hair
cell side), whereas the short block arrow points toward the abneural side (outer hair cell side) of the cochlear duct in both N and R. (S) Pax2 is expressed in
sensory hair cells of the lateral crista and macula utriculi. Abbreviations: as, anterior streak containing both anterior and lateral cristae; cc, common crus; ed,
endolymphatic duct; lc, lateral crista; msc, macula sacculi and organ of corti; mu, macula utriculi; pc, posterior crista; sv, stria vascularis. Orientation arrows: A,
Anterior; D, Dorsal; L, Lateral. Scale bars = 100 Am; D applies to A–C; J applies to E–I; K applies to L; M applies to N; P applies to O; R applies to Q.
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Fig. 4. Development of the vestibular and spiral ganglia in Pax2 mutants. Wild-type (A, C) and Pax2  / (B, D) inner ears at 15.5 dpc. NF68 (A, B) and
Eya1 (C, D) expression patterns in the vestibular (vg, A, B) and spiral (sg, C, D) ganglia of wild-type (A, C) and Pax2 homozygous (B, D) inner ears at 15.5
dpc, respectively. (E–H) Expression patterns of Lfng (E, G) and NeuroD1 (F, H) in wild-type (E, F) and Pax2  / (G, H) inner ears at 10.5 dpc. E and G are
12 Am adjacent sections of F and H, respectively. NeuroD1 positive cells are within the Lfng positive domain for both wild-type and mutants. (I, J) Gata3
expression in the spiral ganglion component of the delaminated neuroblasts in wild-type (I) and mutant (J) inner ears at 11.5 dpc. Arrowheads point to the rim
of the neuroblast cluster. Refer to schematic diagrams in Fig. 3 for planes of sections for A, C and E–H. Scale bars = 100 Am.
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neurons in vestibular and spiral ganglia in Pax2 /
mutants occurs after the delamination process, presumably
due to a lack of neurotrophin support from the macula
sacculi and organ of Corti, respectively.
We also examined the formation of sensory patches in
Pax2 mutants at 15.5 dpc. On the basis of the expression
patterns of Lfng andMyo15a (Figs. 5A, D, lc and mu; n = 12),
all three cristae and the macula utriculi are invariably present
and contain nascent hair cells in Pax2 homozygous inner ears
examined at 15.5 dpc. Awell-defined saccule is not evident in
most of the specimens following paint-fill. However, a
distinct but smaller macula sacculi can be identified within
the enlarged ventral chamber in more than half of the mutants
processed for gene expression analysis (Figs. 5B, E, ms; n =8 out of 12). More ventrally, only a few scattered sensory
patches can be found on the medial side (Figs. 5B, C,
arrowheads). The association of these sensory patches with
genes normally expressed in the cochlea suggests that they
are part of a rudimentary organ of Corti (see below). In
addition, some of these sensory patches also express the hair
cell marker, Myo15a (Figs. 5E, F).
Cell death in cochlear duct of Pax2 mutants
To better elucidate the mechanisms underlying the co-
chlear duct phenotype in Pax2 mutants, we performed cell
proliferation and TUNEL assays. Because paint-fill analysis
indicates that the cochlear phenotype in Pax2 mutants is
already evident at 12 dpc, we evaluated cell proliferation
Fig. 5. Development of sensory patches and cochlear duct in Pax2 mutants. A, B and C are 12 Am adjacent sections of D, E and F from the same Pax2 mutant
inner ear in a dorsal to ventral direction at 15.5 dpc. (A) Lfng and (D) Myo15a expression patterns in the lateral crista (lc) and macula utriculi (mu). Expression
patterns of Lfng (B) and Myo15a (E) in the macula sacculi (ms). Arrowheads in B, C, E and F point to the scattered sensory patches located in the cochlea.
Inserts in B, C, E and F show an overlap between Myo15a and Lfng expression domains. Only one of the Lfng positive domains in C is also positive for
Myo15a expression (arrowheads in insert of C and F). Refer to the 15.5 dpc schematic diagram in Fig. 4 for approximate planes of sections. (G–J) Cell
proliferation and apoptosis in the cochlea of Pax2 mutants at 11.5 dpc. Brightfield micrographs showing apoptotic (G, I) and BrdU (H, J) labeled nuclei as
brown profiles. Panels in H and J have been counterstained with hematoxylin. (G, H) Adjacent wild-type cochlear sections processed for TUNEL (G) and anti-
BrdU staining (H). (G) Two small regions of apoptosis are evident in the wild-type cochlea (arrows). The anterior region of apoptosis overlaps with a cold spot
of proliferation in H. (I, J) Adjacent cochlear sections from Pax2  / ears processed for TUNEL (I) and anti-BrdU staining (J). (I) Extensive apoptosis is
observed in the lateral and postero-medial regions of the mutant cochlea (arrows). A concomitant reduction in BrdU positive cells is observed in the same
regions (J, arrows). Scale bars = 100 Am; A applies to B–F; J applies to G–I.
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not observe a consistent change in either parameter at 10.5
dpc (n = 3). However at 11.5 dpc, we observed an increase
in TUNEL positive cells and a decrease in BrdU positive
cells. In the normal inner ear, there are some apoptotic cells
in the anterior and posterior regions of the cochlea (Fig. 5G,
arrows). The TUNEL positive cells in the anterior region of
the cochlear duct are located in a low proliferation zone
(Fig. 5H, arrows). Except for this low proliferation zone
(Fig. 5H, arrows), the epithelial cells are fairly uniformlylabeled for BrdU, including cells in the region that normally
express Pax2 (compare Fig. 5H with Figs. 3G and 3I). In
Pax2 mutants, an increase in programmed cell death is
present in the lateral as well as postero-medial regions of
the cochlear duct (Fig. 5I, arrows, n = 4), a region that
normally expresses Pax2 (Figs. 3G, I). A concomitant
decrease in BrdU-labeled cells is also present in the same
regions undergoing rapid cell death (Fig. 5J, arrows, n = 3).
By 12.5 dpc, apoptosis within the otic epithelia is greatly
reduced in the mutants (data not shown).
Fig. 6. Gene expression patterns of Eya1, Otx2 and Gata3 in the cochlea of Pax2 mutants at 15.5 dpc. Expression patterns of Eya1(A), Lfng (B) and Otx2 (C) in
adjacent sections of wild-type cochlea at 15.5 dpc. (A) Eya1 is expressed in the posterior wall of the cochlear duct. (B) Lfng is expressed in the sensory region
of the cochlea. (C) Otx2 is expressed in the Reissner’s membrane and its expression domain abuts the expression domain of Eya1 (arrrowhead). (D, E) Lfng (D)
and Gata3 (E) expression patterns in adjacent sections of wild-type cochlea. Arrows in E point to the borders of Gata3 domain in the cochlear duct. Expression
patterns of Eya1 (F), Lfng (G) and Otx2 (H, arrows) in adjacent sections of Pax2 mutant cochlea at 15.5 dpc. The relationship of Eya1 and Otx2 expression
domains is maintained in Pax2 mutants (arrowheads in F, H). Arrows in G point to Lfng positive sensory patches. (I, J) Expression patterns of Lfng (I) and
Gata3 (I) in adjacent sections of Pax2 mutants. Arrows in J point to the Gata3 positive domain anterior to the Lfng positive, sensory region (I). Abbreviation:
sg, spiral ganglion. Orientation arrows: A, anterior; L, lateral. All cross sections of wild-type cochlea are oriented with neural side toward the left. Refer to the
15.5 dpc schematic diagram in Fig. 4 for planes of sections for mutant embryos. Scale bars = 100 Am; C applies to A and B; E applies to D; H applies to F and
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To determine the consequences of such extensive cell
death on various regions of cochlear duct development, we
examined the expression patterns of several region-specific
genes. Despite the hierarchy of pax-eya-six regulation that
has been shown in other organs, both Eya1 and Six1
expression patterns appear normal in Pax2 / otocysts
(Zheng et al., 2003). We further examined if Eya1 expres-
sion is affected in the developing cochlea of the Pax2
mutants. Normally, Eya1 is expressed in the spiral ganglion
and the posterior wall of the cochlear duct that includes the
organ of Corti (Figs. 6A, B; Kalatzis et al., 1998), whereas
Otx2 is a marker for the Reissner’s membrane (Fig. 6C;
Morsli et al., 1999). The two expression domains abut each
other toward the neural (ganglion) side of the cochlear duct
(Figs. 6A, C; arrowhead). In the Pax2 mutants, the Eya1
expression domain remains associated with the Lfng posi-
tive sensory domain, except both domains are found medi-
ally (Figs. 6F, G) rather than in the normal posterior position
G; I applies to J.Fig. 7. Gene expression patterns in the cochlea of Pax2  / mutants at 15.5 dp
positive, sensory region, (B) Bmp4 positive, Hensen’s and Claudius’ cell regions
Adjacent sections showing the Lfng positive sensory region (D, arrowheads) overla
G) Adjacent sections showing Lfng positive sensory region (F, arrow) overlaps wit
to normal Pnd expression found between the lateral crista and macula utriculi. (H
sensory region. (I) Raldh2 is expressed in the stria vascularis (arrows) and mesen
expressed in melanocytes within the stria vascularis. (K–M) Adjacent sections of
the Raldh2 (L) and Trp2 (M) positive regions. Inserts in K, L and M are higher mag
positive cells are spanning both sides of the Lfng positive, sensory domain (arrow).
with the Reissner’s membrane. Arrows in M point to the Trp2 positive melanoc
epithelial region. Abbreviations: lc, lateral crista; ms, macula sacculi; mu, macula
cochlea is toward the left. Scale bars = 100 Am; A applies to B–C; G applies toby this stage (Figs. 6A, B). However, there is no obvious
difference in the relationship of Eya1 and Otx2 expression
patterns, the two domains remain juxtaposed (Figs. 6F, H,
arrowhead).
Gata3 is normally broadly expressed in the cochlear duct
at this stage, with an expression domain spanning from the
greater epithelial ridge to the stria vascularis and includes
the sensory region (Figs. 6D, E; Karis et al., 2001). The
Gata3 expression domain, though always present, is often
reduced in the Pax2 mutants (n = 5). The specimen in Fig.
6J shows Gata3 expression localized anterior to the Lfng
positive sensory domain but not posterior to it (Figs. 6I, J,
arrows).
Because Pax2 is primarily expressed toward the abneural
side (beyond the outer hair cells region) of the cochlear duct
(Figs. 3I, M, N, block arrow), we further examined genes
specifically expressed between the outer hair cells and stria
vascularis regions. In a normal cochlea, Bmp4 is expressed
in the Hensen’s and Claudius’ cells adjacent to the outer hair
cells (Figs. 7A, B; Morsli et al., 1998). Pnd is expressed inc. A, B and C are 12 Am adjacent sections of wild-type cochlea. (A) Lfng
, and (C) Pnd positive, external sulcus region in wild-type cochlea. (D, E)
ps with the Bmp4 positive region (E, arrowheads) in the mutant cochlea. (F,
h Pnd positive region (G, arrows) in mutants. An arrowhead in G is pointing
–J) Adjacent sections of wild-type cochlea. (H) Lfng is expressed in the
chymal cells adjacent to the Reissner’s membrane (arrowheads). (J) Trp2 is
Pax2 mutants. The Lfng positive sensory region (K) is encompassed within
nification of tissues outlined within the box, and show that Raldh2 and Trp2
(L) Arrowheads point to Raldh2 expression in mesenchymal cells associated
ytes in aberrant positions that are not associated with the Raldh2 positive
utriculi. Orientation arrows: A, anterior; L, lateral. Neural side of wild-type
D–F; I applies to H and J; L applies to K and M.
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hair cell region (Fig. 7C; Everett et al., 1999; Royaux et al.,
2003). In the Pax2 / inner ears, Bmp4 positive cells are
intermingled within the Lfng positive domain (Figs. 7D, E,
arrowheads). However, the expression of Bmp4 in thecristae is normal (data not shown). Pnd expression also
co-localizes with the Lfng positive sensory domain in the
cochlear duct (Figs. 7F, G; arrows). The normal expression
of Pnd between the lateral crista and the macula utriculi,
however, is unaffected in Pax2 mutants (Fig. 7G, arrow-
Q. Burton et al. / Developmental Biology 272 (2004) 161–175170head; Everett et al., 1999). Taken together, these results
suggest that the expression of Bmp4 or Pnd in the inner ear
is not dependent on Pax2, but the lack of Pax2 affects the
development of cells expressing Bmp4 and Pnd in the
cochlea.
In addition, Raldh2 is not expressed in the Lfng positive
sensory region (Fig. 7H) but is expressed in the stria
vascularis (Fig. 7I, arrows) as well as the mesenchymal
cells adjacent to the Reissner’s membrane (Fig. 7I, arrow-
heads; Romand et al., 2001). Trp2, a marker for the neural
crest-derived melanocytes, is co-localized with Raldh2 in
the stria vascularis region (Fig. 7J; Steel et al., 1992). In the
Pax2 mutants, the location of the Raldh2 positive, epithelial
region overlaps with some of the Lfng positive, sensory
regions instead (Figs. 7K, L). However, most of the Raldh2
positive mesenchymal cells (Fig. 7L, arrowheads) are asso-
ciated with the lateral region of the cochlear duct that is
Otx2 positive (Fig. 6H, arrows), similar to wild-type (Figs.
6C and 7I; Morsli et al., 1999). In addition, in the Pax2
mutants, Trp2 positive cells are no longer restricted to the
Raldh2 positive epithelial region. Instead, Trp2 positive
cells are scattered in different areas of the cochlear duct
(Fig. 7M, arrows). Some Trp2 positive cells are located
anterior as well as posterior to some of the sensory patches
(Figs. 7K, M), similar to patterns observed for Bmp4, Pnd
and Raldh2.
Taken together, these results indicate that the tissue
specification of the cochlear duct is affected in the Pax2Fig. 8. Gene expression patterns in the endolymphatic duct of Pax2 mutants. E
endolymphatic duct of wild-type (A, B, C) and Pax2 homozygous (D, E, F) inner e
region of the endolymphatic duct that resemble the wild-type pattern. Orientationmutants, in particular the posterior and lateral walls of the
cochlear duct. The lack of Pax2 causes cell death and arrest
of cochlear development around 11.5 dpc. We reasoned that
apoptosis is a consequence of gene expression changes due
to absence of Pax2 activity most likely before 11.5 dpc.
However, expression patterns of the genes tested thus far
including Gata3, Gbx2, Foxg1, Eya1, Lfng and NeuroD are
all normal in the mutants at the otocyst stage (data not
shown).
Gene expression in endolymphatic duct of Pax2 /
mutants
The endolymphatic duct/sac is important for maintaining
the fluid homeostasis of the membranous labyrinth. Improp-
er development or differentiation of the endolymphatic duct/
sac has been shown to disrupt this process and result in
swelling of the membranous labyrinth (Everett et al., 2001;
Hulander et al., 2003). Therefore, the variability in the sizes
of the semicircular canals as well as the cochlear duct could
be due to a functionally compromised endolymphatic duct/
sac in the mutants. In normal inner ears, Delta, Serrate and
Pnd are expressed in subsets of cells within the endolym-
phatic sac (Figs. 8A–C; Everett et al., 1999; Morrison et al.,
1999). We examined the mutant inner ears for these tran-
scripts and found that some specimens do express these
genes in the most apical region of the endolymphatic duct
(Figs. 8D–F, n = 2/4), resembling those cells found nor-xpression patterns of Pnd (A, D), Delta (B, E), and Serrate (C, F) in the
ars at 15.5 dpc. Arrows in D, E and F point to positive cells in the most distal
arrows: A, anterior; L, lateral. Scale bar = 100 Am.
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Morrison et al., 1999). These results suggest that despite
the malformations of the endolymphatic duct and sac in
Pax2 mutants, some progression of cellular differentiation
occurred.Discussion
Cell autonomous role of Pax2 in inner ear development
Transcription factors are thought to be cell autonomous
because a transcription factor activates specific gene tran-
scription within a given cell. However, it is conceivable that
a given transcription factor could have indirect non-cell
autonomous roles if one of its downstream genes encodes a
signaling molecule that mediates functions in neighboring
cells. Indeed, Pax2 has a non-cell autonomous role in
kidney development. Pax2 expressed in the metanephric
mesenchyme induces glia cell-derived neurotrophic factor
(GDNF) that is essential for ureteric bud outgrowth during
kidney development (Brophy et al., 2001). Within a specific
organ, comparison of the normal expression pattern of aFig. 9. A schematic diagram summarizing gene expression patterns in wild-type an
the developing cochlear region at 10.5, 11.5 and 15.5 dpc. There is a relative shi
medial sensory region of the cochlea (purple color) at 10.5 dpc is shifted to the po
the antero-lateral domain at 10.5 dpc (Morsli et al., 1999) is shifted to the anterior
positive region (blue color) at 10.5 dpc is in the medial and posterior regions, and
11.5 dpc, the Pax2 positive region is restricted toward the posterior region of the pr
stria vascularis, by 15.5 dpc. Also, the Pax2 positive domain at 10.5 dpc (blue colo
purple color), Hensen’s and Claudius’ cells (H and C, Bmp4 positive, light blue co
by 15.5 dpc (Pax2, Raldh2 and Trp2 positive that are represented by blue, green
(black asterisks) occurs at 11.5 dpc in the region that normally expresses Pax2. As
and Lfng and Otx2 expression domains maintain their medial and lateral locations
various cochlear regions fail to compartmentalize properly: Lfng, Bmp4, Pnd, Rald
section for each stage is shown in the corresponding inner ear diagram. An arro
cochlear duct, respectively. Abbreviations: ES, external sulcus; HC, hair cells; H
Reissner’s membrane; SV, stria vascularis; TM, tectorial membrane. Orientation atranscription factor with regions that are affected by the loss
of this gene product can sometimes reveal non-cell auton-
omous role(s) of the transcription factor.
Our inner ear analysis of Pax2 knockout mice indicates
that there is a good correlation between Pax2 expression
domains and regions that are affected by the loss of Pax2
gene function. For example, Pax2 is not expressed in the
three cristae and semicircular canals, and these structures
formed normally in the mutants. The change in the sizes of
the canals and ampullae are most likely indirect and due to
defects in endolymphatic duct/sac function. On the other
hand, Pax2 expression overlaps with the Lfng expression
domain medially at 10.5 dpc that presumably includes the
prospective maculae and the organ of Corti. While the
macula utriculi forms normally, the macula sacculi is often
affected. In the cochlear anlage, the Pax2 expression domain
is initially very broad, spanning the medial and posterior
domains at 10.5 dpc (Fig. 9A, blue color; Figs. 3A, C). If
one projects this expression domain of Pax2 onto a cochlea
at 15.5 dpc, it would span from the Lfng positive, sensory
region to the border of the stria vascularis and the Reissner’s
membrane, even though Pax2 transcripts are only detected
in the stria vascularis by 15.5 dpc. Interestingly, defects ind Pax2 mutant cochlea. (A) Expression patterns of Lfng, Pax2 and Otx2 in
ft of these expression domains within the growing cochlea over time. The
sterior wall of the cochlear duct. The Otx2 positive region (yellow color) in
wall of the cochlear duct, the Reissner’s membrane, at 15.5 dpc. The Pax2
it overlaps with the Lfng positive region (blue and purple hatched lines). At
esumptive cochlea that develops into the lateral wall of the cochlear duct, the
r in A) differentiates into various regions including, sensory (Lfng positive,
lor), external sulcus (ES; Pnd positive, dark blue color), and stria vascularis
and red colors, respectively). (B) In the Pax2 mutants, massive cell death
a result, the relative regional shift within the cochlear duct does not occur,
, respectively, similar to a wild-type inner ear at 10.5 dpc (A). In addition,
h2, and Trp2 are co-localized in the same region. The approximate plane of
w and block arrow in A point toward the neural and abneural sides of the
and C, Hensen’s and Claudius’ cells; GER, greater epithelial ridge; RM,
rrows: A, anterior; L, lateral; applies to all panels.
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especially from the sensory region to the stria vascularis,
corresponding to this projected expression domain of Pax2
from 10.5 dpc.
Pax2 transcripts are not detected in the cochleo-vestibu-
lar ganglion. There is no obvious defect in the delamination
of neuroblasts at 10.5 dpc, and no increase in apoptosis up
to 11.5 dpc in the Pax2 mutants. The loss of neurons in both
vestibular and spiral ganglia later in development could be
due to a lack of normal neurotrophic supply from the
sensory tissues, even though improper projection of these
neurons to nuclei in the central nervous system could also be
involved.
In non-sensory regions, a fusion of the endolymphatic
duct and common crus occurs in all Pax2 mutants exam-
ined. The presence of Pax2 in the endolymphatic duct as
well as the lateral region of the common crus could both
contribute to the failure of separation between these two
structures. The correspondence of the sensory and non-
sensory defects in the Pax2 mutants with the normal
expression domains of Pax2 within the inner ear suggests
that Pax2 primarily plays a cell autonomous role within the
inner ear. However, we cannot rule out the possibility that
the neural tube defect in Pax2 mutants also contributes to
the inner ear phenotype observed because the inner ears are
more severely affected in mutants with exencephaly.
Pax2 and hair cell formation
Pax2 is expressed in all the nascent sensory hair cells in
the mouse (Lawoko-Kerali et al., 2002). In the zebrafish
inner ear, pax2.1, a homolog of Pax2, is thought to interact
with the Notch signaling pathway in mediating the number
of sensory hair cells (Riley et al., 1999). Zebrafish generate
hair cells at an early stage of inner ear development,
whereas hair cell genesis is a relatively later event in mice.
Pax2 appears to have earlier roles in proper morphogenesis
of the mouse inner ear, including the sensory tissue deve-
lopment of the macula sacculi and organ of Corti. We did
not determine if lack of Pax2 increases the number of hair
cells in mice as it does in zebrafish. Nevertheless, hair cells
do appear to form normally in Pax2 mutant mice.
Pax2 in cochlear development
The cochlear duct develops from the ventral portion of
the otic vesicle. The molecular mechanisms underlying the
morphogenesis of the cochlear duct are largely unknown. In
the mouse, the anlage of the cochlear duct first extends
ventrally in an antero-medial direction and then coils
laterally to form 1.75 turns (Morsli et al., 1998). In addition
to changes in the orientation of the cochlear duct during its
outgrowth, there is also a positional shift of different regions
within the cochlear duct, based on expression patterns of
three genes, Lfng, Pax2 and Otx2 (Fig. 9A). At 10.5 dpc, the
Lfng positive domain (Fig. 9A, purple color) that includesthe presumptive sensory tissues of the cochlea spans the
medial region of the cochlear anlage, and this Lfng domain
is more restricted at 11.5 dpc. By 15.5 dpc, the sensory
tissue of the cochlea is localized to a small region in the
posterior wall of the cochlear duct. At 10.5 dpc, the Pax2
positive domain (Fig. 9A, blue color) encompasses the
medial and posterior regions of the cochlear anlage. Pax2
expression is quickly restricted to mostly the posterior
region of this anlage at 11.5 dpc and is localized to the stria
vascularis, the lateral wall of the cochlear duct by 15.5 dpc
(Fig. 9A). The Otx2 domain (Fig. 9A, yellow color; Morsli
et al., 1999) which is located in the lateral region of the
cochlear anlage, is in the Reissner’s membrane, the anterior
wall of the cochlear duct, by 15.5 dpc. On the basis of these
relative changes in expression domains over time, we
extrapolate that there is a relative shift of regions within
the cochlear duct during development such that the medial,
posterior and lateral walls of a cochlear anlage form the
posterior, lateral and anterior walls of a mature cochlear
duct, respectively (Fig. 9A).
The lack of Pax2 causes massive cell death in the
presumptive cochlear duct. As a result, morphogenesis is
affected. The cochlear duct fails to extend normally based
on paint-fill analysis. The positions of the Lfng and Otx2
domains resemble the orientation of a normal cochlear duct
at 10.5 or 11.5 dpc rather than at 15.5 dpc (Figs. 9A, B),
suggesting that the lack of Pax2 also affects the relative
regional shift within the cochlear duct. The overlap of the
Bmp4 expression domain with that of Lfng in mutant
cochlea at 15.5 dpc also resembles the wild-type pattern at
early stages (Morsli et al., 1998). Together, these results
indicate that there is an arrest of cochlear development in
Pax2 mutants starting around 11.5 dpc. It is not clear how
the relative shift in domains normally relates to the global
extension and coiling of the cochlear duct. An attractive
hypothesis is that differential growth within various
domains of the cochlear duct, governed by genes such as
Pax2 and Otx, is a major force responsible for proper
extension, orientation, and coiling of the cochlear duct. In
line with this hypothesis, analyses of knockout mice show
that both Otx1 and Otx2 are important for the proper coiling
and growth of the cochlear duct (Cantos et al., 2000; Morsli
et al., 1999). However, the cochlear phenotypes resulting
from the lack of Otx1 and Otx2 are not as rudimentary as
those shown here for the Pax2 / inner ears, suggesting
that Pax2 plays an earlier and more important role in proper
outgrowth and coiling of the cochlear duct.
Despite the arrest of cochlear outgrowth, some later
appearing cochlear genes such as Pnd, Trp2 and Raldh2
are activated in the mutant cochlear duct, even though their
expression domains are aberrant. The Bmp4, Pnd, Trp2,
Raldh2 expression domains, which are in separate compart-
ments spanning from the outer hair cell region to the stria
vascularis in a normal cochlea, are all co-localized in the
mutants, together with some of the sensory tissues (Fig. 9B).
It is not clear if the co-localization of some of these genes in
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undergone relative normal fate specification but have ab-
normal positions within the cochlea due to a lack of proper
morphogenesis. Alternatively, it is possible that cells be-
tween the sensory region and the stria vascularis share a
common lineage within a normal cochlear anlage. If so, the
lack of Pax2 may affect the proper cell fate specification in
this region and cause aberrant co-expression of genes that
are normally expressed in separate cell types and regions of
the cochlea. Interestingly, cell lineage studies using replica-
tion defective retroviruses have demonstrated a common
lineage between supporting cells and cells in the abneural
region of the cochlear duct in chicken (Fekete et al., 1998).
Therefore, it is conceivable that the mutant phenotype is
primarily due to a failure of cell fate specification. There is
additional evidence that suggests cell fate specification is
not normal in the mutant inner ear. The aberrant locations of
the neural crest derived, Trp2 positive melanocytes in the
mutants suggests that cell signaling in the cochlea that
normally attracts the melanocytes to the correct region of
the cochlear duct is disrupted.
In contrast, the region outside of the Pax2 expression
domain, the Reissner’s membrane, appears relatively normal
in the mutants, based on the expression of Otx2 in the
epithelium and Raldh2 in the adjacent mesenchyme (Fig.
9B). These results further support the hypothesis of a cell
autonomous role of Pax2 in cochlear development.
Upstream regulators and downstream targets of Pax2 in
inner ear development
In Drosophila eye imaginal disc, the pax6 gene, ey,
functions upstream of both eya and so (sine oculis, a Six
homolog; Halder et al., 1998). Expression of both Eya1 and
Eya2 are also dependent on Pax6 activity during mamma-
lian eye development (Xu et al., 1997). However, while a
eya-six relationship may occur in the inner ear (Xu et al.,
1999; Zheng et al., 2003), it is not clear if Pax2 acts
upstream of Eya1 and Six1 in this organ. First, neither
Eya1 nor Six1 expression is affected in Pax2 mutants (Xu
et al., 2003; Fig. 6F). Second, both Eya1 and Six1 knockout
mice display much more severe inner ear defects than Pax2
mutants (Ozaki et al., 2004; Xu et al., 1999, 2003). These
results suggest that Eya1 and Six1 are not direct downstream
targets of Pax2. However, it is conceivable that Pax2 shares
redundant functions with other Pax genes in the inner ear
and that these Pax genes maintain Eya1 and Six1 expression
in Pax2 mutants. Pax8, another member of the Pax 2-5-
8 subclass of Pax genes shares homology with Pax2 and has
an expression domain similar to that of Pax2 in the otocyst
(Xu et al., 1999, 2003). Pax8, however, does not seem to be
required for the proper morphogenesis of the inner ear. Our
preliminary paint-fill analysis of perinatal Pax8 / inner
ears indicates that their gross anatomy is normal (Schwarz
and Wu, unpublished observation). A delay in tissue mat-
uration of the Pax8 / inner ears due to the lack of thyroidgland in these animals has also been reported (Christ et al.,
2004). The inner ears of a double knock out of Pax2 and
Pax8 remain to be evaluated. Nevertheless, based on the
overlapping but different expression patterns of the two Pax
genes with Eya1 and Six1 in the developing mouse inner
ear, a pax-eya-six hierarchy, if it exists, would most likely be
region-specific, rather than present in all otic epithelial cells
(Kalatzis et al., 1998; Ozaki et al., 2004; Xu et al., 2003).
A complementary relationship of Pax2 and Gata3 ex-
pression patterns exists in the dorsal region of the mouse
otocyst (Lawoko-Kerali et al., 2002). The lack of Pax2
could result in an expansion of Gata3 expression
domain. However, such expansion was not observed in
the Pax2 / otocysts (data not shown). In the cochlea
where the expression patterns of both genes overlap, the
expression of Gata3 is usually reduced. In addition to
Gata3, the expression patterns of other genes such as Pnd,
Bmp4 and Raldh2 are also aberrant in the Pax2 /
cochlear ducts. However, because these genes are all acti-
vated in the Pax2 mutant inner ears indicate that the
expression of these genes does not require Pax2. Direct
downstream targets of Pax2 remain elusive. Our BrdU and
apoptosis studies indicate that Pax2 is normally expressed in
a region that undergoes active proliferation in the cochlea
(compare Fig. 5H with Figs. 3G and I), and the lack of Pax2
activity affects the survival of cells within the Pax2 expres-
sion domain (Fig. 5I). Taken together, we postulate that
downstream targets of Pax2 are most likely involved in cell
proliferation and survival, in a cell autonomous fashion.
Pax2 is one of the earliest genes to be activated in the
otic placode (Nornes et al., 1990; Puschel et al., 1992;
Rinkwitz-Brandt et al., 1995, 1996). It is not clear what
factors induce Pax2 expression in the otic placode. The
maintenance of Pax2 expression in the inner ear is thought
to require Sonic hedgehog (Riccomagno et al., 2002).
Pax2 mutants as animal models for human deafness
syndromes
Pax2 knock out mice were reported to display agenesis
of the cochlea and the absence of the spiral ganglion (Torres
et al., 1996). Our analyses indicate that the cochlear phe-
notype is less severe than reported. However, this difference
in severity of cochlear phenotype could be due to a
difference in the genetic background. The earlier study
was conducted with mice on a 129sv background, while
this study was conducted primarily with mice with a mixed
129sv/C57BL/6 background. It is possible that the pheno-
type is more severe in a pure 129sv background. When we
backcross the Pax2 line with a mixed 129S6/C57BL/6
hybrid line (Taconic) instead of C57BL/6, we detect a small
percentage of heterozygous mice with an abnormal inner ear
phenotype (based on paint-fill analysis, one out of nine
heterozygotes from three litters), even though the homozy-
gous phenotype (n = 3) is similar to the ones generated by
crossing with C57BL/6 mice. Variable penetrance of exen-
Q. Burton et al. / Developmental Biology 272 (2004) 161–175174cephaly in Pax2 heterozygotes due to differences in genetic
background has been observed (Torres et al., 1996).
Nevertheless, the inner ear phenotype described here
closely resembles the inner ears of Pax21neu mice which
carry a mutation in Pax2 that is identical to a human
family segregating renal-coloboma syndrome (Favor et al.,
1996). The inner ears of Pax21neu mice were described as
missing a saccule and to have an enlarged ventral portion
continuous with the enlarged endolymphatic duct. Gross
abnormalities were similar to the mutant, paint-filled ears
shown here. The similarities in inner ear phenotypes
between the knockout and Pax21neu suggest that the
frameshift mutation most likely resulted in a functionally
null Pax2 protein, as previously proposed (Favor et al.,
1996).
Interestingly, some patients with renal-coloboma syn-
dromes suffer from high frequency hearing loss (Sanyanusin
et al., 1995; Schimmenti et al., 1997). Even though the
etiology of the hearing loss is not known in these patients
and the gross anatomy of the inner ears has not been
examined, their defects could be a very mild form of the
phenotypes observed in mice. Despite the repertoire of
genes analyzed in the Pax2 mutants, immediate downstream
targets of Pax2 remain elusive. A global comparison of gene
expression between wild-type and mutant otocysts using
microarray approaches may provide candidates for direct
downstream targets of Pax2. Therefore, these mutant lines
will continue to serve as important tools in deciphering the
etiology of syndromes associated with human deafness.Acknowledgments
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